• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特发性炎性肌病的分类标准。

Classification criteria for the idiopathic inflammatory myopathies.

作者信息

Targoff I N, Miller F W, Medsger T A, Oddis C V

机构信息

VA Medical Center, Oklahoma City, OK, USA.

出版信息

Curr Opin Rheumatol. 1997 Nov;9(6):527-35. doi: 10.1097/00002281-199711000-00008.

DOI:10.1097/00002281-199711000-00008
PMID:9375282
Abstract

Inasmuch as the clinical features of the idiopathic inflammatory myopathies are not easily differentiated from those of other similar rheumatic and neurologic conditions, diagnosis is often difficult. Various classification criteria for polymyositis and dermatomyositis have been suggested by a number of investigators. The most commonly accepted and used criteria include symmetric proximal muscle weakness, serum elevations of muscle enzymes, the classic electromyographic and muscle biopsy findings of inflammatory myopathy, and the typical skin rash of dermatomyositis. Although these criteria are clinically useful, they can result in misdiagnoses and inappropriate therapies. They also result in heterogeneous patient groups being selected for clinical and laboratory studies. Furthermore, they do not include recent findings related to the myositis-specific autoantibodies and magnetic resonance imaging of muscle that have been found to be important adjuncts in assessing patients with muscle weakness or elevations of muscle enzymes. A modification to the Bohan and Peter criteria is proposed to include myositis-specific autoantibodies and magnetic resonance imaging. This proposal could initiate productive discussions and investigations of the sensitivity and specificity of new classification criteria for myositis and could ultimately enhance our treatment capabilities.

摘要

由于特发性炎性肌病的临床特征不易与其他类似的风湿性和神经疾病相区分,诊断往往很困难。许多研究者提出了多种关于多发性肌炎和皮肌炎的分类标准。最常被接受和使用的标准包括对称性近端肌无力、肌肉酶血清升高、炎性肌病的典型肌电图和肌肉活检结果,以及皮肌炎的典型皮疹。尽管这些标准在临床上有用,但它们可能导致误诊和不恰当的治疗。它们还导致在临床和实验室研究中选择了异质性的患者群体。此外,它们没有包括与肌炎特异性自身抗体和肌肉磁共振成像相关的最新发现,而这些发现已被证明是评估肌无力或肌肉酶升高患者的重要辅助手段。有人提议对博汉和彼得标准进行修改,纳入肌炎特异性自身抗体和磁共振成像。这一提议可能引发关于肌炎新分类标准的敏感性和特异性的富有成效的讨论和研究,并最终提高我们的治疗能力。

相似文献

1
Classification criteria for the idiopathic inflammatory myopathies.特发性炎性肌病的分类标准。
Curr Opin Rheumatol. 1997 Nov;9(6):527-35. doi: 10.1097/00002281-199711000-00008.
2
Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies.基于临床表现和肌炎特异性自身抗体的特发性炎性肌病新分类系统的建立。
JAMA Neurol. 2018 Dec 1;75(12):1528-1537. doi: 10.1001/jamaneurol.2018.2598.
3
Inflammatory myopathies.炎性肌病
Baillieres Clin Rheumatol. 1995 Aug;9(3):497-514. doi: 10.1016/s0950-3579(05)80255-9.
4
Including myositis-specific autoantibodies improves performance of the idiopathic inflammatory myopathies classification criteria.纳入肌炎特异性自身抗体可提高特发性炎性肌病分类标准的效能。
Rheumatology (Oxford). 2019 Dec 1;58(12):2331-2333. doi: 10.1093/rheumatology/kez253.
5
Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients.基于重叠综合征特征和自身抗体的特发性炎性肌病新分类:对100名法裔加拿大患者的分析
Medicine (Baltimore). 2005 Jul;84(4):231-249. doi: 10.1097/01.md.0000173991.74008.b0.
6
Diagnosis and classification of idiopathic inflammatory myopathies.特发性炎性肌病的诊断与分类
J Intern Med. 2016 Jul;280(1):39-51. doi: 10.1111/joim.12524.
7
Classification, diagnosis, and management of idiopathic inflammatory myopathies.特发性炎性肌病的分类、诊断和治疗。
J Rheumatol. 2013 May;40(5):550-64. doi: 10.3899/jrheum.120682. Epub 2013 Mar 15.
8
Comparison of the 2017 EULAR/ACR criteria with Bohan and Peter criteria for the classification of idiopathic inflammatory myopathies.比较 2017 年 EULAR/ACR 标准与 Bohan 和 Peter 标准在特发性炎性肌病分类中的应用。
Clin Rheumatol. 2019 Jul;38(7):1931-1934. doi: 10.1007/s10067-019-04512-6. Epub 2019 Mar 22.
9
Reclassification of Korean patients with polymyositis and dermatomyositis based on the Bohan and Peter criteria by the 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies.根据 2017 年欧洲抗风湿病联盟/美国风湿病学会成人和青少年特发性炎性肌病分类标准对韩国多发性肌炎和皮肌炎患者进行 Bohan 和 Peter 标准再分类。
Korean J Intern Med. 2021 Mar;36(2):441-446. doi: 10.3904/kjim.2019.149. Epub 2019 Dec 30.
10
Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features.重新定义皮肌炎:一种新诊断标准的描述,该标准可区分单纯皮肌炎与具有皮肌炎特征的重叠性肌炎。
Medicine (Baltimore). 2014 Nov;93(24):318-332. doi: 10.1097/MD.0000000000000222.

引用本文的文献

1
Treatment guidelines for idiopathic inflammatory myopathies in adults: a comparative review.成人特发性炎性肌病的治疗指南:一项比较性综述。
Rheumatology (Oxford). 2025 Jun 1;64(6):3288-3302. doi: 10.1093/rheumatology/keaf116.
2
Anti-FHL1 autoantibodies in adult patients with myositis: a longitudinal follow-up analysis.成年肌炎患者中的抗FHL1自身抗体:一项纵向随访分析。
Rheumatology (Oxford). 2025 Mar 1;64(3):1482-1492. doi: 10.1093/rheumatology/keae317.
3
Performance of the 2017 EULAR/ACR Classification Criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a scoping review.
2017年欧洲抗风湿病联盟/美国风湿病学会成人及青少年特发性炎性肌病及其主要亚组分类标准的性能:一项范围综述。
Clin Exp Rheumatol. 2024 Feb;42(2):403-412. doi: 10.55563/clinexprheumatol/vuc5py. Epub 2024 Feb 28.
4
From data to diagnosis: how machine learning is revolutionizing biomarker discovery in idiopathic inflammatory myopathies.从数据到诊断:机器学习如何彻底改变特发性炎性肌病的生物标志物发现。
Brief Bioinform. 2023 Nov 22;25(1). doi: 10.1093/bib/bbad514.
5
Contribution of Complement, Microangiopathy and Inflammation in Idiopathic Inflammatory Myopathies.补体、微血管病和炎症在特发性炎性肌病中的作用。
J Neuromuscul Dis. 2024;11(1):5-16. doi: 10.3233/JND-230168.
6
Retrospective Study Shows That Serum Levels of Chemokine CXCL10 and Cytokine GDF15 Support a Diagnosis of Sporadic Inclusion Body Myositis and Immune-Mediated Necrotizing Myopathy.回顾性研究表明,趋化因子CXCL10和细胞因子GDF15的血清水平有助于散发性包涵体肌炎和免疫介导的坏死性肌病的诊断。
Brain Sci. 2023 Sep 25;13(10):1369. doi: 10.3390/brainsci13101369.
7
Epidemiology of the idiopathic inflammatory myopathies.特发性炎症性肌病的流行病学
Nat Rev Rheumatol. 2023 Nov;19(11):695-712. doi: 10.1038/s41584-023-01033-0. Epub 2023 Oct 6.
8
Retinal microvascular and microstructural alterations in the diagnosis of dermatomyositis: a new approach.视网膜微血管和微观结构改变在皮肌炎诊断中的应用:一种新方法。
Front Med (Lausanne). 2023 May 25;10:1164351. doi: 10.3389/fmed.2023.1164351. eCollection 2023.
9
Myositis-specific Antibodies: Overview and Clinical Utilization.肌炎特异性抗体:概述与临床应用
Rheumatol Immunol Res. 2022 Apr 20;3(1):1-10. doi: 10.2478/rir-2022-0001. eCollection 2022 Mar.
10
The Role of Quantitative and Semi-quantitative [F]FDG-PET/CT Indices for Evaluating Disease Activity and Management of Patients With Dermatomyositis and Polymyositis.定量和半定量[F]FDG-PET/CT指标在评估皮肌炎和多发性肌炎患者疾病活动度及管理中的作用
Front Med (Lausanne). 2022 Apr 15;9:883727. doi: 10.3389/fmed.2022.883727. eCollection 2022.